Rucha Patil: Haematocon 2026 – Advancing Haematology Through Science, Collaboration and New Connections
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a post on LinkedIn:
“Haematocon 2026|Ahmedabad|12–15 november 2026
Four days of science, learning, reconnecting, and some exciting new collaborations!
A few highlights:
Crashing two workshops (with good reason!): One on bleeding disorders, led by the amazing Dr. Sukesh Nair, and another on flow cytometry in Primary Immunodeficiency Disorders, led by my very own brilliant and ever-inspiring Dr. Vandana Puri.
Taking charge of Scientific Hall C on 14 November, as a friendly favour to Dr. Amit Khurana, who has always been more than happy to support the Mumbai Haematology Group conferences.
Invited faculty, speaking on ‘What’s New in the Diagnosis and Monitoring of Haemophilia.’ The session focused on laboratory monitoring challenges with newer non-factor therapies, including emicizumab, concizumab and fitusiran, the potential pitfalls and misleading results when conventional coagulation tests are used, and the importance of point-of-care diagnostic technologies, particularly in resource-limited settings where laboratory facilities are not readily available.
But perhaps the best part of Haematocon is what happens beyond the scientific sessions!
It is one of those wonderful platforms where you meet your favourite colleagues from across the country, catch up on old times, exchange ideas, brainstorm new research projects, build collaborations and, of course, find time to chill and have fun.”

Other posts featuring Rucha Patil on Hemostasis Today.
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease
-
Nov 19, 2026, 05:31Lance Reed: One Donation, Multiple Lives
-
Nov 19, 2026, 05:20ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance